The urinary catheter is a long hollow flexible tube needed for emptying the bladder and collecting the urine in a drainage bag. The material of the tube may be rubber, silicone, or plastic. If the bladder is not emptied, the pressure is created in the kidney, which, under severe conditions, may lead to kidney failure. The major driving forces are the rising prevalence of urinary incontinence, the growing geriatric population, the increasing rates of obesity, and the technological advancements in the material used for catheters. The rising prevalence of urinary incontinence (UI) is expected to drive the market. For instance, according to the National Association for Incontinence, nearly 200 million people are affected by urinary incontinence (UI). As per WomensHealth.gov, urinary incontinence is twice as common in women as men, where stress urinary incontinence is most common among pregnant women, giving birth, or going through menopause. Thus, the rising prevalence of urinary incontinence is driving the market.
However, the risk of catheter-associated urinary tract infection (CAUTI) and alternative treatment options for urinary incontinence are likely to hinder the market growth.
Rising Incidences Of Urological Diseases
The urinary catheter market is majorly driven by rising incidences of urological diseases globally. According to the American Urological Association Foundation (AUAF), kidney stones, urinary incontinence (UI), benign prostatic hyperplasia (BPH), and urinary tract infections (UTIs) are among the most common urological diseases. According to the United States Department of Health and Human Services, the overall prevalence of chronic kidney disease (CKD) among the American population is about 14%. Almost half of the individuals with chronic kidney disease (CKD) have diabetes/or cardiovascular diseases. Annually, more than 661,000 Americans suffer from kidney failure, and 468,000 patients are given dialysis. Urinary tract infections (UTIs) are among the most common microbial diseases affecting people of all age groups. Globally, UTIs affect around 150 million people every year. Diabetic patients have a higher risk of developing UTIs and complications associated with them. With a global increase in the diabetic population, complications like dysuria and organ damage associated with UTIs are also on the rise. Hence, with high incidence rates and health complications associated with urological diseases, there is an increasing demand for urinary catheters, propelling the market growth.
The North American market is estimated to grow at a CAGR of 6.3% during the forecast period (2020-2027). North America is the most lucrative market for urinary catheters across the world. The region's growth is due to the well-established healthcare infrastructure and rapid adoption of urinary catheters in the healthcare ecosystem. In the USA, the dominance is driven by the proliferation of various diseases in which catheterization is needed. According to the United States Census Bureau (2017), 47.8 million are diagnosed with these disorders. It is expected that the number will rise to 98.2 million by 2060. The older population has an increased susceptibility to spinal cord injury (SCI), urinary incontinence, and benign prostate hyperplasia. According to the National Association for Incontinence (NAFC), in North America, nearly 200 million people are affected by urinary incontinence. As per WomensHealth.gov, urinary incontinence is twice as common in women as men, where stress urinary incontinence is most common among pregnant women, giving birth, going through menopause. These are the major reasons for the rise in the urinary catheters market in the region. In February 2019, Safe Medical Design Inc. (SMD), a medical device company dedicated to developing safe and cost-effective solutions in urology, announced that the US FDA cleared the Signal Catheter for commercialization US. In the USA, many catheter-based clinical trial studies involve major hospital chains and research centers in collaboration with multinational companies, such as the University of Rochester Medical Center, Massachusetts General Hospital Boston, and others.
According to the Centers for Medicare and Medicaid Services, the national health expenditure had grown by 4.6% in 2017, to nearly 3.5 trillion, currently. Improved regulatory medical device guidelines and reimbursement policies make the United States a country with a higher investment opportunity. It is expected to witness high growth during the forecast period. Spinal surgeries are prevalent in the geriatric population. Moreover, the percentage of the population aged 60 years or above is expected to increase, globally, from 12.7% in 2017 to nearly 21.3% by 2050, as per United Nations 2017 report. Hence, the number of spinal surgeries is also expected to increase. This is expected to drive the growth of the urinary catheters market in the region. Moreover, favorable reimbursement policies and rising interest in advanced urinary catheters are the key factors leading to enhanced urinary catheter demand. Additionally, firms aiming to manufacture advanced urinary catheter products using hydrophilic technology will augment the market growth in the region. According to the American Academy of Family Physicians (AAFP) estimated that every year in the US, there are more than 250,000 surgeries carried out for benign prostate hyperplasia (BPH) with approximately 2 million office visits. This may also arise from injury or trauma to the penis, urethra, or bladder and is also associated with the pregnancy. Also, urinary incontinence affects around 6 million American men and 20 million American women at some point in their lives. Thus, the increasing use of urinary catheters is driving the market in the region. Also, nearly 100 million urinary catheters are sold each year, of which the US accounts for a significant share in buying medical devices. These factors are driving the growth of the market of urinary catheters in North America.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Get your FREE SAMPLE PROPOSAL with a single click!
Our Research Experts are tracking the impact of COVID-19 on various domains across all industry verticals and our market reports are incorporated with these insights.